Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Schildhaus HU"" wg kryterium: Autor


Tytuł :
Molecular pathological profile of brain metastases from a primary adenocarcinoma of the lung
Autorzy :
Hernandez Duran, S
Barrantes-Freer, A
Schatlo, B
Rohde, V
Schildhaus, HU
Bleckmann, A
Pokaż więcej
Temat :
610 Medical sciences
Medicine
ddc: 610
Źródło :
68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS); 20170514-20170517; Magdeburg; DOCMO.03.01 /20170609/
Tytuł :
Rapid tumor progression in a patient with HPV type 16 associated anal squamous cell carcinoma suffering from long-standing Crohn's disease: A case report
Autorzy :
Fischer AK
Krause T
Steinbrück H
Schildhaus HU
Hoppenau C
Hesterberg R
Rüschoff J
Pokaż więcej
Temat :
Crohn's disease
Human papillomavirus (HPV)
anal squamous cell carcinoma
Inflammatory bowel disease (IBD)
immunosuppression
Medicine
Źródło :
Journal of Cancer Research & Therapy, Vol 4, Iss 5, Pp 50-54 (2016)
Tytuł :
Heterogeneity of colorectal cancer liver metastasis – analysis of the EGFR and WNT pathway patterns via High-throughput and bioinformatics profiling
Autorzy :
Conradi, LC
Bleckmann, A
Wolff, A
Hoppenau, C
Scheel, A
Schildhaus, HU
Ghadimi, M
Trümper, L
Korf, U
Pukrop, T
Beißbarth, T
Homayounfar, K
Pokaż więcej
Temat :
610 Medical sciences
Medicine
ddc: 610
Źródło :
132. Kongress der Deutschen Gesellschaft für Chirurgie; 20150428-20150501; München; DOC15dgch639 /20150424/
Tytuł :
Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
Autorzy :
Deml KF
Schildhaus HU
Compérat E
von Teichman A
Storz M
Schraml P
Bonventre JV
Fend F
Fleige B
Nerlich A
Gabbert HE
GaBler N
Grobholz R
Hailemariam S
Hinze R
Knüchel R
Lhermitte B
Nesi G
Rüdiger T
Sauter G
Moch H
Pokaż więcej
Temat :
urologic and male genital diseases
Źródło :
American Journal Surgical Pathology
Tytuł :
[Predictive diagnostics for checkpoint inhibitors].
Autorzy :
Schildhaus HU; Institut für Pathologie, Universitätsklinikum Essen, Essen, Deutschland.
Weichert W; Institut für Pathologie, Technische Universität München, München, Deutschland. .
Pokaż więcej
Transliterated Title :
Prädiktive Diagnostik für Checkpoint-Inhibitoren.
Źródło :
Der Pathologe [Pathologe] 2021 May 06. Date of Electronic Publication: 2021 May 06.
Typ publikacji :
English Abstract; Journal Article; Review
Czasopismo naukowe
Tytuł :
Ga-68-FAPI as diagnostic tool in sarcoma: Data from the FAPI-PET prospective observational trial.
Autorzy :
Kessler L; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Ferdinandus J; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Hirmas N; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Bauer S; Department of Medical Oncology, West-German Cancer Center, University of Duisburg-Essen, Germany.
Dirksen U; Department of Pediatrics III, West-German Cancer Center, University Hospital Essen, Germany.
Zarrad F; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Nader M; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Chodyla MK; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany.
Milosevic A; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany.
Umutlu L; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany.
Schuler M; Department of Medical Oncology, West-German Cancer Center, University of Duisburg-Essen, Germany.
Podleska LE; Department of Tumor Orthopedics and Sarcoma Surgery, University Hospital Essen, Germany.
Schildhaus HU; Department of Pathology, University Hospital Essen, Germany.
Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Germany.
Hamacher R; Department of Medical Oncology, West-German Cancer Center, University of Duisburg-Essen, Germany.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Apr 30. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy.
Autorzy :
Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany. Electronic address: .
Preuß C; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Roeper J; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius Hospital, Medical Campus University of Oldenburg, Oldenburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Metzenmacher M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Eberhardt W; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Stropiep U; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius Hospital, Medical Campus University of Oldenburg, Oldenburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Wedeken K; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius Hospital, Medical Campus University of Oldenburg, Oldenburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Reis H; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Herold T; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Darwiche K; Department of Pulmonary Medicine, Section of Interventional Pneumology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Aigner C; Department of Thoracic Surgery and Endoscopy, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Stuschke M; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Schildhaus HU; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Schmid KW; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Falk M; Institute for Hematopathology Hamburg, Hamburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Heukamp L; Institute for Hematopathology Hamburg, Hamburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Tiemann M; Institute for Hematopathology Hamburg, Hamburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Griesinger F; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius Hospital, Medical Campus University of Oldenburg, Oldenburg, Germany; Lung Cancer Network NOWEL, Oldenburg, Germany.
Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Apr 16; Vol. 149, pp. 211-221. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies